Logo

    no surprises act

    Explore " no surprises act" with insightful episodes like "Pharma and Biotech Daily: The Latest News and Insights in the Industry", "What physicians need to know about the No Surprises Act with Emily Carroll, JD & George Cox, JD", "Community Health Plans Building trust & interoperability", "What physicians need to know about the implementation of the No Surprises Act" and "Understanding the New Surprise Billing Regulations" from podcasts like ""Pharma and BioTech Daily", "AMA Update", "The Dish on Health IT", "Moving Medicine" and "The Advancing Surgical Care Podcast"" and more!

    Episodes (8)

    Pharma and Biotech Daily: The Latest News and Insights in the Industry

    Pharma and Biotech Daily: The Latest News and Insights in the Industry
    Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Today, we have several news updates from the industry. Let's dive in.Cigna has sold its Medicare businesses to HCSC for $3.7 billion, exiting a sector that has seen its earnings potential shrink. Despite the sale, Cigna still sees Medicare Advantage as an area for future growth. In other news, the No Surprises Act prevented 10 million surprise bills in the first nine months of 2023, according to insurer groups AHIP and BCBSA. However, they also criticized providers for allegedly abusing the billing dispute resolution process set up by the law. Tenet Healthcare plans to sell four California hospitals to UCI Health for $975 million as part of its efforts to reduce debt. An AI-powered solution is being touted as a way to alleviate the critical shortage of medical coders and boost efficiency and revenue in healthcare systems.In the biotech world, Arch is raising $3 billion for startup investing, continuing its track record of creating and investing in biotech startups. Vertex's non-opioid drug showed positive results in a major trial for pain relief, although it fell short compared to a widely prescribed opioid on a secondary goal. Cell therapy for lupus is gaining attention, with several drugmakers conducting trials in this area. Biogen has decided to discontinue its controversial drug Aduhelm and return the rights to the original developer. AstraZeneca and Daiichi are seeking FDA approval for their drug Enhertu as a "tumor agnostic" treatment. Roche has made changes to its early-stage pipeline, focusing on experimental programs for obesity.In recent developments, Philips has stopped selling sleep and respiratory devices in the US due to a consent decree from the FDA. Teleflora used a documentary approach in its marketing campaign to overcome cynicism about love, while Lay's released time-loop ads inspired by the movie "Groundhog Day." Ocean Spray revealed its first major brand overhaul in over 20 years, and Miller Lite turned fans into walking beer ads for the Super Bowl. McDonald's also made headlines with its Hamburglar character hitting the road in a getaway vehicle. Pepsi Wild Cherry created excitement around the Super Bowl with a Vegas sphere takeover.Cigna is still interested in the Medicare Advantage market despite selling its Medicare division. Providence plans to settle allegations of not fulfilling charity care obligations. Walgreens has confirmed additional layoffs as part of its ongoing efforts to achieve cost savings. The Department of Health and Human Services has finalized a rule on telehealth at opioid treatment programs. A new study found that the availability of telehealth for mental healthcare varies by state. Healthcare executives must consider workforce and consumer concerns about generative AI, according to a survey.Alto Neuroscience and Fractyl Health have both gone public in separate IPOs, joining the recent surge of biotech IPOs. The CMS has sent initial price proposals to drugmakers as part of efforts to reform drug pricing. Kyverna Therapeutics is planning an IPO to support the development of its anti-CD19 CAR-T therapies. The Department of Health and Human Services released new data showing that Americans pay significantly more for prescription drugs compared to other developed countries. The ASGCT Annual Meeting will cover topics such as genome editing, muscular dystrophy, and cell and gene therapy.In financial news, AbbVie reported a beat in its Q4 earnings but expects sales decline in oncology and immunology. Bristol Myers Squibb exceeded Q4 estimates and is looking towards new products and M&A following exclusivity loss. Merck posted $60 billion in sales for 2023 driven by Keytruda and HPV vaccine. GlaxoSmithKline saw an increase in sales thanks to vaccines for RSV and shingles. Takeda reported lower profits but closed a $300 million deal with Protagonis

    What physicians need to know about the No Surprises Act with Emily Carroll, JD & George Cox, JD

    What physicians need to know about the No Surprises Act with Emily Carroll, JD & George Cox, JD
    Emily Carroll, a senior attorney for the AMA’s Advocacy Resource Center, and George Cox, the AMA’s director of legislative counsel, share what physicians need to know about the No Surprises Act and how the AMA's advocacy team is working on behalf of physicians and patients as the Act evolves. American Medical Association CXO Todd Unger hosts. Guidance for implementation of the No Surprises Act: https://www.ama-assn.org/delivering-care/patient-support-advocacy/implementation-no-surprises-act Summary of the August final rule: https://www.ama-assn.org/system/files/ama-summary-nsa-final-rules.pdf Toolkit for physicians on disputing out-of-network payments: https://www.ama-assn.org/system/files/ama-nsa-idr-toolkit.pdf Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://www.ama-assn.org/advocacy-news

    Community Health Plans Building trust & interoperability

    Community Health Plans Building trust & interoperability

    This episode features special guests, Ceci Connolly, President and CEO of Alliance of Community Health Plans or ACHP and Virginia (Ginny) Whitman, Sr. Manager of Public Policy for ACHP. They join host, Pooja Babbrah, filling in for Ken Kleinberg and co-host, Jocelyn Keegan to discuss ACHP’s perspective and work on building trust between payers and providers and why that’s important, how price transparency policy is translating into real-world changes, and the cultural shift happening as more data becomes shareable. 

    Pooja kicked off the episode by having Jocelyn briefly introduce herself and share what she's looking forward to learning from the discussion. Jocelyn shared that she recently had the good fortune of presenting at an ACHP conference in May where she met a lot of the community members.

    Jocelyn went on to share that she’s been with POCP for six years as the Payer Practice Lead and has been focused on interoperability and the convergence of sharing clinical data between payers and providers to help automate interactions like prior authorization and support value-based care. 

    Pooja then asked each guest to introduce themselves and share how they came to work with ACHP. 

    Ceci Connolly shared that she is the president and CEO of ACHP now but had a 25 year-long career in journalism before catching the healthcare bug. She recounted that she was covering healthcare and specifically that passage of the Affordable Care Act which led her to pursue a second act of her career which entailed working the McKinsey and helping them set up the Center for Health Reform before moving on to lead the Health Research Institute at PwC before landing at ACHP. She expressed how fortunate she feels to havean amazing group of members and a passionate team that’s aligned to take healthcare where she believes it needs to go. 

    Ginny Whitman introduced herself sharing that she’s been with ACHP for almost four years and that it was only a few months into her tenure that a dear friend and colleague pulled her into the world of health policy. She continued by saying that she’s been focused on exploring what health plans need, what their pain points are and where can they excel and do wonderful and creative things to support their communities. 

    Pooja then asked for Ceci to share more about ACHP, it’s mission and the work it’s been focused on most recently. 

    Ceci responded by saying that the ACHP member criteria is essentially also the mission. ACHP represents not-for-profit provider aligned regional health plans adding that many of those are plans that are in big integrated systems across the

    She explained that many ACHP members are smaller and local in their communities with tight relationships with their provider community which often include risk arrangements which ACHP believes is a model with a bright future for healthcare. 

    Ceci went on to say that ACHP members are very much about access for all in their communities and focused on health as opposed to acute care. She relayed that the ACHP roadmap set by the board of directors includes setting a course to really serve the consumer, meet members where they are and improving transparency and data fluidity so consumers and providers both have the data they need to make the best decisions. Affordability is also a big focus for ACHP, they release a report each year and have taken a pledge on two chronic diseases, diabetes, and cardiovascular to start to move the needle in our members' communities on those.

    Ceci expressed that she is very positive about the recent law President Biden just signed on inflation reduction that included provisions about drug pricing which is a huge pain point for ACHP members and their communities. She explained that she is also pleased about the enhanced affordable care act provisions as well. 

    Pooja then transitioned the conversation to focus on the theme of a recent ACHP event that highlighted the need to build and improve trust between payers and providers. Pooja asked Ceci to provide her assessment of the historic level of trust between payers and providers and why it’s important to redefine and strengthen these relationships?

    Ceci responded by explaining that the recent event was Ginny’s brainchild and would like her perspective on this topic. She went on to explain that ACHP has been hearing from all directions that trust is an issue. 

    Ceci expressed that they were thrilled to have a keynote by Dr. Jan Berger who has written the book on the theme of trust in healthcare. There is a strong foundation to work from because ACHP members are grounded in their local communities. She explained that developments in the technology and the data arena can be positives when it comes to trust, but also pose potential risks. 

    Ginny added that ACHP member plans have close relationships with their provider systems and provider groups but that sometimes the technical infrastructure doesn’t support good communication. Part of the focus of the ACHP event was how to make technical level changes to improve that communication with providers ACHP members value so much. 

    Pooja then asked if there were any specific initiatives or programs ACHP members have employed to improve trust with providers? 

    Ginny explained that there are so many programs but one example she described was a vaccination campaign in Minnesota where the community health partners, using data, recognized they were missing communities of color in the vaccine effort. Stakeholders from across the community collaborated to create education and vaccination events to close those gaps. She went on to explain some other examples of partnerships and collaborations between ACHP members and their communities that help build on the foundation of trust. 

    Pooja asked Jocelyn to comment on payer provider trust and data exchange based on her work as the program manager of Da Vinci.

    Jocelyn started her response by making the observation that there is a duality with how big nationals come into these regional markets and work hard to make themselves seem small and local. They will do things like sponsoring local teams, getting involved in local charities to make themselves seem like part of the community. The small plans, on the other hand, who are already connected to local provider system plans and the community, are spending all this effort to make themselves seem bigger and seem wider and deeper right out into the market. Jocelyn expressed that she finds this juxtaposition interesting. 

    Jocelyn went on to say that the reusability of the work that's emerging in the industry around things like DaVinci and other FHIR initiatives and other standards helps create a more level playing field for smaller plans to make investments in interoperability and more easily tackle regulatory challenges. 

    Pooja then asked what ACHP, and its members are doing around price and patient cost transparency. 

     

    Ginny responded by saying that many ACHP members had price estimator or cost estimator tools prior to any regulations coming out which put everyone in a very good place when regulations did drop. Most plans had either already met the requirements or only needed to make small adjustments to do so. She explained that the challenge now is how to incentivize the providers and patients to use these tools. 

    Ginny expressed some concern around some future regulations particularly with some of the overlap of the No Surprises Act and the transparency and coverage rule. 

    I'm not that worried about it, but I will say that I, I do have some hesitations and reserves when it comes to future regulations that we are expecting, um, particularly some of the overlap that was in the no surprises act part of the consolidated appropriations act and what's in the transparency and coverage rule.

    Ceci added that some ACHP plans are further along in this journey and are incorporating quality information for instance which starts to get at value. She expressed that healthcare is a funny world where transparency is currently defined with price. She explained that if you look at travel and are looking for a hotel, one might look at the cheapest hotel or the cheapest flight but maybe location or a comfortable bed is more important to you. 

    It's the same in healthcare. Some consumers are going to be looking for that value package. Ceci added that some ACHP members have gotten very sophisticated and developed tools that are so easy to use but consumer uptake is still very small and slow.

    To make her point, Ceci highlighted a health plan in Michigan that developed a super slick tool that’s extremely easy to use. The tool shows where plan members are in their deductible, what the co-pay is and where services are located. This plan put in financial incentives, and they have seen some uptick in the utilization, but it's going to take a long time and a big, big effort. In the meantime, there are all these machine-readable files out there creating an insurmountable mound of data that is challenging for payers to sift through. 

    Jocelyn responded by expressing the important role of standardization in helping solve many of these issues. She explained that so many stakeholders are so focused on using standards to meet regulatory requirements they lose sight of the real-world problems that need solving like how to get patient important cost and value information so they can make better decisions about where they get their healthcare. 

    Jocelyn continued to explain that here is a huge investment related to many of these transparency projects and when there is so little uptake, it can be discouraging but that the more we normalize the data using standards we can reduce the overhead cost.

    Jocelyn explained that it’s important to get the right information to the patient at the right point in time. She went on to use an analogy of when someone is in Target shopping, they may look at their Amazon app to see if they can find the item cheaper but sometimes, if a person is on their way to a birthday party and hasn’t shopped for a present yet, convenience may be more important in that moment than price. 

    Jocelyn added that the question is how we can create information parody so the provider team and the patient have equal information about the patient's benefits so they can discuss a treatment, procedure or test and where or even when a patient may want to go to get maximum coverage. 

    Ceci jumped in to provide an example of how a mid-Atlantic plan not only provides patients with where they can get a colonoscopy but will mail plan members a home test kit with all the pertinent information about risk factors. This helps make patients more health literate while also allowing them to take more control of their health in the convenience of their own home on their schedule. She added that it's about data, communication, and trust. If your health plan and provider sends information about a colonoscopy and home kit saying this would be good for you to do, you’re probably going to do it. So, it’s a win, win. 

    Ceci explained that using data in this way to support the patient in a transparent way, it goes a long way in repairing trust in the healthcare system. Adding that if a patient is surprised by an astronomical bill, that's not going to repair their trust, but when data can be used to support conversations leading to a strategic care and financial plan, progress can be made. 

    Pooja then zoomed out the conversation to focus on how interoperability projects are making more data flow and changing how businesses operate. Pooja asked Ceci and Ginny to describe how ACHP is counseling their members on how to approach making this cultural shift. 

    Ceci shared that they emphasize that this is going to be hard work. She pointed back to the early days of electronic health record adoption which took about a decade. Change is hard, especially when it's something personal, like healthcare. Ceci and Ginny both expressed that they just continually beat on the drum to remind their member plans to not give up and make sure the interoperability and serving patients the best way possible through the best use of data must be a top priority, but it will take a long time. 

    Jocelyn agreed that the cultural shift for both big and small plans is still in the early days but that there are some early adopters starting to make more substantial changes. She added that of course there are still organizations that are still checking the regulatory box versus making real, systemic changes but as CMS and ONC continue this unprecedented alignment and increased communication with the industry about their priorities, it may make it easier for stakeholders to make the changes needed. Ultimately leaders need to keep evangelizing and painting the picture of the future and what it looks like from a roadmap perspective. 

    So really laying out where things are headed from a regulatory perspective, [00:34:00] it does still surprise me that folks are taking the checkup, check the box approach. But I wholeheartedly agree with CC and Jenny, I think that this is about evangelizing and painting that picture forward, helping people understand what the roadmap work is and that it includes APIs and a patient-centered approach. Some will lead and some will follow. 

    In closing, Pooja asked the guests if there were any final messages or calls to action, they wanted to put out to the industry. 

    Ceci responded by saying that she thinks this is an incredibly exciting and a bit unnerving time and that she wanted to share the mantra all ACHP members get on a laminated card which is “think big, start small, act fast” 

    Pooja closed out the episode by thanking guests, Ceci and Ginny before reminding listeners that they can find and subscribe to The Dish on Health IT podcast on Apple podcast, Spotify, or whatever platform you use to pick up podcasts and that videos of episodes can be found on the POCP YouTube Channel. 

    What physicians need to know about the implementation of the No Surprises Act

    What physicians need to know about the implementation of the No Surprises Act
    The No Surprises Act (NSA) is here. In this episode, Chair of AMA board of Trustees, Dr. Bobby Mukkamala, is joined by experts from Manatt Health to discuss the implementation of the NSA, including many of the issues addressed in the AMA’s surprise billing toolkit. Speakers also tackle enforcement challenges and the interaction between state and federal surprise billing requirements. Find AMA’s surprise billing toolkit here: https://www.ama-assn.org/delivering-care/patient-support-advocacy/implementation-no-surprises-act#toolkit-for-physicians📺 Follow the AMA on YouTube: @americanmedicalassociation  🎥 Watch #AMAUpdate for the latest in health care news for physicians: https://bit.ly/AMA_Update 📧 Subscribe to AMA Morning Rounds newsletter, with the news you need every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds  🎧 Listen to our latest podcast episodes now: https://bit.ly/AMA_Podcasts  📲 Download AMA Connect for news, podcasts, video updates and learning in one place: https://apple.co/3URzNES

    Understanding the New Surprise Billing Regulations

    Understanding the New Surprise Billing Regulations

    In this episode of the Advancing Surgical Care Podcast, ASCA Chief Executive Officer Bill Prentice talks with Kara Newbury, ASCA regulatory counsel and director of government affairs, and Alex Taira, ASCA regulatory policy and research manager, about the new surprise billing regulations that took effect at the beginning of 2022. The conversation addresses both new prohibitions on certain billing practices as well as new requirements for good faith cost estimates for certain patients. ASC administrators will want to listen to this short, informative program to learn how to stay current and compliant with this new, consequential law.

    What physicians need to know about the No Surprises Act with Emily Carroll, JD

    What physicians need to know about the No Surprises Act with Emily Carroll, JD
    AMA CXO Todd Unger discusses the No Surprises Act and what it means for patients and physicians with Emily Carroll, JD, a senior legislative attorney for the AMA’s Advocacy Resource Center. Stay up to date on all the latest advocacy news by subscribing to AMA Advocacy Update: https://www.ama-assn.org/advocacy-news📺 Follow the AMA on YouTube: @americanmedicalassociation  🎥 Watch #AMAUpdate for the latest in health care news for physicians: https://bit.ly/AMA_Update 📧 Subscribe to AMA Morning Rounds newsletter, with the news you need every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds  🎧 Listen to our latest podcast episodes now: https://bit.ly/AMA_Podcasts  📲 Download AMA Connect for news, podcasts, video updates and learning in one place: https://apple.co/3URzNES

    Taking the Surprise Out of Surprise Medical Bills

    Taking the Surprise Out of Surprise Medical Bills

    One of the most important pieces of health care legislation was signed into law last December. The No Surprises Act was designed to protect consumers from surprise medical bills, those medical bills that come unexpectedly and often with high price tags. But heading into 2022, hospitals and insurers are still trying to determine how to implement the legislation's requirements. So what's at stake with the legislation? And how does it  affect patients, hospitals and insurers? Lisa McDonnel of UnitedHealthcare and Michael Wentzien of Naviguard explain in this week's episode. 

    No Surprises Act: Known Impacts on Surprise Medical Bills & What's Next

    No Surprises Act: Known Impacts on Surprise Medical Bills & What's Next

    Last week, the Biden administration issued an interim final rule to implement critical components of the No Surprises Act (NSA).

    Building on the Affordable Care Act, the NSA includes new patient protections against surprise medical bills.

    About one in five insured adults had an unexpected medical bill from an out-of-network provider, according to a 2020 Kaiser Family Foundation survey. A study released this week found that about one in five newborn hospitalizations or childbirth deliveries result in receiving a surprise medical bill.

    These surprise medical bills can cause financial stress to patients and their families.

    Listen to Health Affairs' Senior Editors Leslie Erdelack and Chris Fleming break down the interim final rule, how it will impact surprise medical bills or "balance billing," and what we can expect regarding what's next.

    Check out the July issue on Borders, Immigrants & Health.

    Register for the July 12 Event on Border Health.

    Related Links:

    Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io